Profilo
Dr. Jan Brinkman, MD PhD, is on the Board of Directors at Boston Therapeutics, Inc.
He received his MBA from INSEAD, a doctorate degree from the University of Florence, and a doctorate degree from Erasmus University Rotterdam.
Precedenti posizioni note di Jan Brinkman
| Società | Posizione | Fine |
|---|---|---|
| NANOMIX CORPORATION | Direttore/Membro del Consiglio | 23/02/2016 |
Formazione di Jan Brinkman
| Erasmus University Rotterdam | Doctorate Degree |
| INSEAD | Masters Business Admin |
| University of Florence | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Boston Therapeutics, Inc.
 Boston Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Boston Therapeutics, Inc. is a pharmaceutical company, which engages in the development, manufacture, and commercialization of novel compounds based on complex carbohydrate chemistry. Its products are designed to help manage blood sugar, treat pre-diabetes, and diabetes related pathologies. Its drug candidates comprises of BTI320, BTI-410, and IPOXYN. The company was founded by David Platt and Kenneth A. Tassey Jr. on August 24, 2009 and is headquartered in Lawrence, MA. | Health Technology |
- Borsa valori
- Insiders
- Jan Brinkman
